Mainstay Medical to raise $108 million in a round co-led by Soffinova Partners and Ally Bridge Group.

France Ireland Hong Kong 16 February 2021

Mainstay Medical, a Dublin, Ireland-based medical device producer, announced that it completed a funding round totalling $108 million.

The money was raised from investos co-led by French group Sofinnova Partners, and Ally Bridge Group, and included participations from Fountain Healthcare Partners and KCK Group.

Mainstay, founded in 2008 by Danny Sachs, is a medical device company focused on bringing to market an innovative implantable neurostimulation system, ReActiv8, for people with disabling Chronic Low Back Pain. The company was listed on junior markets in Dublin and Paris but returned to private status in 2020.

Total investments received (USD): 108M